Skip to search formSkip to main contentSkip to account menu

almotriptan

Known as: 1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine, almotriptan [Chemical/Ingredient] 
A sulfonamide triptan with extracerebral, intracranial vasoconstrictor activity. Almotriptan selectively binds to and activates serotonin 5-HT 1B and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A simple, sensitive, specific, rapid and accurate Spectrophotometric assay was described for detection of almotriptan malate (ALM… 
2018
2018
Objective: Chronic migraine is a headache syndrome accompanied by nausea, dyspepsia, depression, and insomnia and it reduces the… 
2016
2016
The aim of present study is to determine the effect of various diluents and super disintegrants in various ratios on drug release… 
2011
2011
The present study was designed to develop almotriptan tablets and invitro evaluation of almotriptan tablets, an antimigraine drug… 
Review
2011
Review
2011
Frovatriptan 2.5 mg has been investigated for the treatment of moderate or severe migraine attacks in six placebo-controlled… 
Review
2006
Review
2006
The discovery of the triptans (selective serotonin agonists 5HT1B/1D), with 7 compounds (almotriptan, eletriptan, frovatriptan… 
Review
2006
Review
2006
Headache is an almost universal human pain experience; it accounts for 2% of all emergency department visits, and it can be the… 
2005
2005
Review
2002
Review
2002
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…